Venous thromboembolism in hospitalized patients receiving chemotherapy for malignancies at Japanese community hospital: prospective observational study

Table 1 Baseline clinical characteristics (n = 97)

Characteristic	No. of patients	(%)
Age (yr.)	65	±12.1^a
Sex ratio (M:F)	47	:50
Body mass index (kg/m²)	22	± 3.4^a
Reduced mobility^c	10	10
Previous chemotherapy	19	20
Time from tumor onset (yr.)	3	(1–12)^b
Using anti-VGEF antibody	17	18
Recent (≤1 month) surgery	6	6
Recent (≤1 month) radiation	3	3
Complication
Rheumatic arthritis	3	3
Chronic heart failure	1	1
Tumor type
Digestive cancer
Colon or rectum	26	27
Stomach	18	19
Esophagus	6	6
Pancreas	7	7
Other^d	2	2
Female reproductive system cancer
Breast	22	23
Ovary	3	3
Other tumor
Lung cancer	2	2
Urinary tract cancer	2	2
Urachus cancer	1	1
Cancer of unknown primary	4	4
Sarcoma^e	3	3
Lymphoma	1	1
Distant metastases	65	67

VEGF vascular endothelial cell growth factor
^aMean ± standard deviation. ^bMedian (interquartile range). ^cBedrest with bathroom privileges for at least three days, either due to patient’s limitation or on physician’s order. ^dLiver and biliary tract. ^ethymus and prostate.

ISSN: 1471-2407